European filing for Erbitux in colorectal and head and neck cancers delayed until 2003 April 25, 2002
Genasense potentiates activity of anticancer agents, retains activity against resistant leukemia April 25, 2002
Nonsteroidal inhibitor of 17-alpha-hydroxylase/17,20 lyase with potential in prostate cancer April 25, 2002